For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Kardium Inc.

USPTO Granted Patents = 160

EPO Patents = 25

Trademarks = 2

Forward Citations = 2,819

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Daniel Gelbart (51 out of 149 patents)

Daniel Robert Weinkam (50 out of 50 patents)

Saar Moisa (48 out of 49 patents)

4. Douglas Wayne Goertzen (41 out of 41 patents)

5. Fernando Luis De Souza Lopes (33 out of 38 patents)

6. Daniel Martin Reinders (29 out of 29 patents)

7. Samuel Victor Lichtenstein (27 out of 37 patents)

8. Ashkan Sardari (21 out of 21 patents)

9. Peter Josiah Hawes (21 out of 29 patents)

10. Jeffery Charles Brewster (17 out of 17 patents)

11. Roxanne Wai Tak Louie (15 out of 15 patents)

12. Danai Bisalputra (15 out of 16 patents)

13. Michael Hermann Weber (15 out of 15 patents)

14. Jorge Jaramillo (14 out of 14 patents)

15. Aldo Antonio Salvestro (14 out of 29 patents)

Core Competencies:

Transducer Activation

Steerable Catheter

Ablation Techniques

Catheter Navigation

Intra-Cardiac Mapping

Medical Device Systems

Pulsed Field Ablation

Medical Device Flushing

High-Density Electrode Devices

Bodily Cavities

Bodily Lumens

Elongate Members

160 patents: Sort by Forward Citations

1. 12496127 - High-density electrode-based medical device system (2025-12-16),

2. 12440166 - Systems and methods for facilitating improved transducer-to-tissue contact (2025-10-14),

3. 12434036 - Medical system including steerable catheter (2025-10-07),

4. 12383325 - Enhanced medical device for use in bodily cavities, for example an atrium (2025-08-12),

5. 12383208 - Systems and methods for selecting, activating, or selecting and activating transducers (2025-08-12),

6. 12376796 - Systems and methods for activating transducers (2025-08-05),

7. 12376795 - Systems and methods for activating transducers (2025-08-05),

8. 12349955 - Enhanced medical device for use in bodily cavities, for example an atrium (2025-07-08),

9. 12324636 - Systems and methods for selecting, activating, or selecting and activating transducers (2025-06-10),

10. 12324622 - Systems and methods for ablating tissue (2025-06-10),

11. 12310680 - Catheter navigation systems and methods (2025-05-27),

12. 12268439 - Intra-cardiac mapping and ablating (2025-04-08),

13. 12245827 - Catheter navigation systems and methods (2025-03-11),

14. 12239391 - Catheter navigation systems and methods (2025-03-04),

15. 12226172 - Systems and methods for selecting, activating, or selecting and activating transducers (2025-02-18),

Kardium is a medical technology company that focuses on the development and commercialization of innovative solutions for the treatment of atrial fibrillation (AF), a common and potentially life-threatening heart rhythm disorder. Their flagship product, the Globe Mapping and Ablation System, combines advanced mapping and ablation technologies to deliver efficient and comprehensive therapy for AF. With a commitment to improving patient outcomes, Kardium aims to transform the way AF is treated and bring hope to millions of people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

160 Patents

#2 in Burnaby

#76 in Canada

#5,011 in the World

Burnaby, Canada

Kardium Inc.

Forward Citations = 2,819

38 inventors:

Daniel Gelbart (51 out of 149 patents)

Daniel Robert Weinkam (50 out of 50 patents)

Saar Moisa (48 out of 49 patents)

4. Douglas Wayne Goertzen (41 out of 41 patents)

5. Fernando Luis De Souza Lopes (33 out of 38 patents)

Please report any incorrect information to support@idiyas.com

Loading…